Mitra Ramgopal
Stock Analyst at Sidoti & Co.
(3.02)
# 1,221
Out of 4,820 analysts
21
Total ratings
73.33%
Success rate
33.14%
Average return
Main Sectors:
Stocks Rated by Mitra Ramgopal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCPC Balchem | Upgrades: Buy | $175 | $153.64 | +13.90% | 6 | Feb 22, 2022 | |
| TRNS Transcat | Upgrades: Buy | $60 | $85.13 | -29.52% | 2 | May 19, 2021 | |
| AMN AMN Healthcare Services | Maintains: Buy | $72 → $70 | $19.15 | +265.63% | 5 | Jun 16, 2020 | |
| ADUS Addus HomeCare | Maintains: Buy | $96 → $115 | $100.55 | +14.37% | 4 | Jun 1, 2020 | |
| USPH U.S. Physical Therapy | Maintains: Buy | $128 → $80 | $69.96 | +14.36% | 1 | Mar 27, 2020 | |
| BEAT HeartBeam | Maintains: Buy | $81 → $75 | $1.95 | +3,746.15% | 3 | Feb 27, 2020 |
Balchem
Feb 22, 2022
Upgrades: Buy
Price Target: $175
Current: $153.64
Upside: +13.90%
Transcat
May 19, 2021
Upgrades: Buy
Price Target: $60
Current: $85.13
Upside: -29.52%
AMN Healthcare Services
Jun 16, 2020
Maintains: Buy
Price Target: $72 → $70
Current: $19.15
Upside: +265.63%
Addus HomeCare
Jun 1, 2020
Maintains: Buy
Price Target: $96 → $115
Current: $100.55
Upside: +14.37%
U.S. Physical Therapy
Mar 27, 2020
Maintains: Buy
Price Target: $128 → $80
Current: $69.96
Upside: +14.36%
HeartBeam
Feb 27, 2020
Maintains: Buy
Price Target: $81 → $75
Current: $1.95
Upside: +3,746.15%